FibroGen Inc (FGEN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

About FibroGen Inc

FibroGen, Inc. is a biopharmaceutical company based in San Francisco, California, dedicated to developing and commercializing innovative therapies aimed at addressing significant unmet medical needs. Specializing in treatments for anemia associated with chronic kidney disease and fibrotic diseases, FibroGen utilizes its proprietary technology platforms to pioneer novel therapeutics that enhance patient outcomes. The company strategically positions itself within the biopharmaceutical landscape...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for FibroGen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FGEN pay dividends?

FibroGen Inc (FGEN) does not currently pay a regular dividend.